FOX Business’ Gerri Willis reports the federal 340B Drug Pricing Program is facing allegations of fraud and hospital profiteering, with critics warning low-income patients are being left behind while healthcare systems reap billions.
0:00 – The 340B Program Fraud Allegations
0:32 – From Safety Net to Hospital Windfall
1:02 – $81 Billion: The Second Largest Drug Program
1:15 – CASE STUDY: 300% Markups on Migraine Meds
1:43 – Diverting Profits to Wealthy Communities
2:02 – The American Hospital Association Response
Subscribe to Fox Business: https://bit.ly/2D9Cdse
Watch more Fox Business Video: https://video.foxbusiness.com
Watch Fox Business Network Live: http://www.foxnewsgo.com/
FOX Business Network (FBN) is a financial news channel delivering real-time information across all platforms that impact both Main Street and Wall Street. Headquartered in New York — the business capital of the world — FBN launched in October 2007 and is one of the leading business networks on television. In 2025 it opened the year posting double-digit advantages across business day, market hours and total day viewers in January. Additionally, the network continued to lead business news programming, with each business day program placing among the top 15 shows, while FBN delivered its highest-rated month since April 2023 with market hours.
Follow Fox Business on Facebook: https://www.facebook.com/FoxBusiness
Follow Fox Business on Twitter: https://twitter.com/foxbusiness
Follow Fox Business on Instagram: https://www.instagram.com/foxbusiness
